Table 6.

Examples of primary outcomes reported in ClinicalTrials.gov register with primary outcome reported in abstract classified as “partial agreement”

	Abstract	ClinicalTrials.gov	Classified as
1	Retinal thickness in the peak oedematous field on the retinal maps of the fast module scans of the Stratus OCT	Retinal thickness by fast retinal thickness mapping by optical coherence tomography at 0,2,4,8,10,15,20,30,60,90,120,and 180 min after last swallow of glycerol	Extra information in ClinicalTrials.gov
2	Visual acuity	Mean change in best corrected visual acuity as assessed by number letters read correctly on ETDRS eye chart at starting test distance of 4 meters from baseline to 1,3,6 months	Extra information in ClinicalTrials.gov
3	ETDRS best corrected visual acuity at 2, 6 and 12 weeks; OCT at 2 and 6 weeks; fluorescein angiography at 2 and 6 weeks	Best corrected visual acuity, OCT foveal thickness, fluorescein angiogram	Extra information in abstract
4	Change from baseline in major symptom complex score over period 1, consisting of runny nose, sniffles, itchy nose, nose blows, sneezes, and watery eyes	Mean change from baseline of major symptoms related to seasonal allergic rhinitis	Extra information in abstract
5	Retinal detachment rate; surgery-related complications; patient comfort; refractive change; visual acuity; OCT	Retinal detachment rate at 6 months	Extra complementary information in both sources